External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Rheumatology ACR 2026
Roche and Genentech at

ACR 2026

November 06 - November 11
Orlando, USA / Virtual (Hybrid)
We will be contributing to topics related to
Rheumatology Nephrology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
03:30 PM
Duration 120mins Orlando, USA
Obinutuzumab Achieves Sustained Glucocorticoid Control: An Exploratory Analysis From a Phase III Trial in Active Systemic Lupus Erythematosus
Luca Iaccarino, Włodzimierz Samborski, Sunil Kumar, Asokan Naidoo, Bongin Yoo, Sonja Nick, Oliver Meier, William F. Pendergraft III, Jay P. Garg, Edward M. Vital, Ronald Van Vollenhoven, Richard A. Furie, Eric Morand
Rheumatology - Nephrology | Systemic Lupus Erythematosus - Systemic Lupus Erythematosus

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Unmet Need and Treatment Disparities Among Lupus Patients With Medicaid Insurance in the United States
Jesse Sussell, Zhiyu Xia, Rongrong Wang, William F. Pendergraft III, Maria Dall’Era
Rheumatology - Nephrology | Lupus Nephritis - Lupus nephritis - Systemic Lupus Erythematosus - Systemic Lupus Erythematosus

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 120mins Orlando, USA
Association Between Sustained Peripheral CD19+ B Cell Depletion and Clinical Efficacy of Obinutuzumab in Lupus Nephritis: Post-hoc analyses of the Phase 3 Trial
Richard A. Furie, Olivia Hwang, Bongin Yoo, William F. Pendergraft III, Theodore A. Omachi, Frederic Boissard, Edward M. Vital, Brad H. Rovin, Harini Raghu
Rheumatology - Nephrology | Lupus Nephritis - Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Obinutuzumab Facilitates Tubular Repair in Lupus Nephritis Independently of Histologic or Clinical Response: Post Hoc Analyses of Urine EGF in a Phase III Trial
Harini Raghu, Holly J. Clarke, Juan M. Mejia-Vilet, Ben Lanza, Peiqing Yu, Theodore A. Omachi, William F. Pendergraft III, Brad H. Rovin
Rheumatology - Nephrology | Lupus Nephritis - Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Obinutuzumab Reduces Fatigue and Improves Health-Related Quality of Life: Results from a Phase III Trial in Systemic Lupus Erythematosus
Eric Morand, Laurent Arnaud, Jeannette Andersen, Marta Mosca, Luca Iaccarino, Josefina Cortés-Hernández, Sandrine Jousse-Joulin, Olga Mitrofanova, Oliver Meier, Gene Wallenstein, Peiqing Yu, Jay P. Garg, Maria Dall’Era, Richard A. Furie, Edward M. Vital, Anca D. Askanase, Ronald Van Vollenhoven
Rheumatology - Nephrology | Systemic Lupus Erythematosus - Systemic Lupus Erythematosus

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Impact of Lupus Nephritis Flares on Healthcare Utilization: A Retrospective Cohort Study in the United States Between 2016 and 2025
Jesse Sussell, Jiying Zou, Huong Trinh, Shu Wang, Anisha M. Patel, William F. Pendergraft III, Lisa Lindsay
Rheumatology - Nephrology | Lupus Nephritis - Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:45 PM
Duration 15mins Orlando, USA
Obinutuzumab Induces Histologic Remission and Deep Kidney Parenchymal B-cell Depletion in Patients With Lupus Nephritis: Exploratory Analyses From a Phase III Trial
Richard A. Furie, Brad H. Rovin, Elsa Martins, Cary D. Austin, Harini Raghu, Caleb Chan, Patrick S. Chang, Jay P. Garg, Valeria Alberton, Mittermayer B. Santiago, Gustavo Aroca-Martínez, Fedra I. Palazuelos, Teresa Baczkowska, Jose Alfaro, Jorge Ravelo-Hernández, Luis F. Pinto, Eduardo H. Albiero, Christopher Larsen, Bongin Yoo, Jennifer Pulley, Andrew Thorley, Thomas Schindler, Theodore A. Omachi, William F. Pendergraft, Ana Malvar
Nephrology | Lupus nephritis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:30 PM
Duration 120mins Orlando, USA
Obinutuzumab Induces Rapid and Durable Resolution of Clinical Disease Activity Across Active Clinical SLEDAI-2K Organ Domains in Patients With Systemic Lupus Erythematosus
Edward M. Vital, Elisa Gremese, Katarzyna Romanowska-Próchnicka, Ingrid Louw, Peiqing Yu, Oliver Meier, Olga Mitrofanova, Theodore A. Omachi, Jay P. Garg, Eric Morand, Richard A. Furie, Joan T. Merrill, Anca D. Askanase
Rheumatology - Nephrology | Systemic Lupus Erythematosus - Systemic Lupus Erythematosus

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.